固体臓器移植患者における非ビタミンK抗体経口抗凝固剤の安全性と有効性の評価: 移植センターの総合的な分析
Arzu Nelihan Akgun1, Emir Karacaglar, Senem Has Hasirci
1>From the Department of Cardiology, Ankara Dişkapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
まとめ
非ビタミンK 抗凝固剤 (NOACs) は,心臓発作と出血を予防する上でウォルファリンと同等の安全性と有効性を示しています. これらの発見を確認するには,さらなる研究が必要である.
科学分野:
- 心臓病科
- 腎臓科
- 移植 医学
背景:
- 心房細動 (AF) は,固体器官移植 (SOT) の受容者における一般的な不律です.
- AF患者の脳卒中や全身栓塞を予防するために,口服抗凝固薬は極めて重要です.
- ワルファリンは従来の抗凝固剤であり,ビタミンK抗原性経口抗凝固剤 (NOACs) は新しい代替剤である.
研究 の 目的:
- AFのSOT受容者において,ウォルファリンと比較してNOACの安全性と有効性を評価する.
- これらの患者グループにおける全身性栓塞および大出血の発生率を分析する.
主な方法:
- AFを患った52人のSOT受給者の電子医療記録の遡及分析
- NOACとワルファリンを投与した患者の比較
- 血液と血栓のリスクスコアの評価 (例えば,CHA2DS2-VASc).
主要な成果:
- ほとんどの患者は腎臓移植を受けた (76. 4%) 患者でした.
- ワルファリン群では重度の出血の発生率が高かった (統計的に有意ではない).
- NOAC群における全身性栓塞事件の発生率が高い (統計的に有意ではない).
結論:
- この研究は,トルコのSOT受給者におけるNOACの使用を特徴づける最初の研究である.
- NOACsは,この集団における栓塞事件と出血のリスクを防ぐのにワーファリンと同じくらい有効である.
- 組織は,個々の利益リスクプロファイルに基づくNOACを好みます.
関連する概念動画
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:26Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
01:24Tissue Transplantation
519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519